Neonatal sepsis an old problem with new insights

Virulence

Volumn 5, Issue 1, 2014, Pages 170-178

  Shah, Birju A ^a   Padbury, James F ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Algorithms; Antibiotic prophylaxis; Biomarkers; Epidemiology; Group b streptococcus; Microbiology; Neonatal sepsis; Newer tests; Screening

Indexed keywords

ACUTE PHASE PROTEIN; AMPICILLIN; C REACTIVE PROTEIN; CD11 ANTIGEN; CD64 ANTIGEN; CEFAZOLIN; INHIBITOR PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; PENICILLIN DERIVATIVE; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA; VANCOMYCIN; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER;

ALGORITHM; ANTIBIOTIC RESISTANCE; BLOOD CELL COUNT; CANDIDA ALBICANS; DIAGNOSTIC ACCURACY; ESCHERICHIA COLI; GENOMICS; HUMAN; INTRAPARTUM CARE; MICROBIOLOGY; NEWBORN; NEWBORN SCREENING; NEWBORN SEPSIS; NONHUMAN; PROTEOMICS; PSEUDOMONAS AERUGINOSA; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SERRATIA MARCESCENS; STREPTOCOCCUS AGALACTIAE; VERY LOW BIRTH WEIGHT; ANTIBIOTIC PROPHYLAXIS; BLOOD; EPIDEMIOLOGY; ESCHERICHIA COLI INFECTION; FEMALE; INFANT MORTALITY; NEWBORN DISEASE; NEWER TESTS; PREGNANCY; PREGNANCY COMPLICATION; RISK FACTOR; SCREENING; SEPSIS; STREPTOCOCCUS INFECTION;

ALGORITHMS; ANTIBIOTIC PROPHYLAXIS; BIOMARKERS; EPIDEMIOLOGY; GROUP B STREPTOCOCCUS; MICROBIOLOGY; NEONATAL SEPSIS; NEWER TESTS; SCREENING;

ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; SEPSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 84891699921     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.26906     Document Type: Review

References (101)

1. Camacho-Gonzalez A, Spearman PW, Stoll BJ. Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr Clin North Am 2013; 60:367-89. PMID:23481106; http://dx.doi.org/10.1016/j. pcl.2012.12.003
2. Bizzarro MJ, Raskind C, Baltimore RS, Gallagher PG. Seventy-five years of neonatal sepsis at Yale: 1928-2003. Pediatrics 2005; 116:595-602. PMID:16140698; http://dx.doi.org/10.1542/peds.2005-0552
3. Hornik CP, Fort P, Clark RH, Watt K, Benjamin DK Jr., Smith PB, Manzoni P, Jacqz-Aigrain E, Kaguelidou F, Cohen-Wolkowiez M. Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units. Early Hum Dev 2012; 88(Suppl 2):S69-74. PMID:22633519; http://dx.doi.org/10.1016/S0378-3782(12)70019-1
4. Gerdes JS. Diagnosis and management of bacterial infections in the neonate. [viii-ix.]. Pediatr Clin North Am 2004; 51:939-59, viii-ix. PMID:15275982; http://dx.doi.org/10.1016/j.pcl.2004.03.009
5. Bonadio WA, Hennes H, Smith D, Ruffing R, Melzer-Lange M, Lye P, Isaacman D. Reliability of observation variables in distinguishing infectious outcome of febrile young infants. Pediatr Infect Dis J 1993; 12:111-4. PMID:8426766; http://dx.doi.org/10.1097/00006454-199302000-00001
6. Gerdes JS. Clinicopathologic approach to the diagnosis of neonatal sepsis. Clin Perinatol 1991; 18:361-81. PMID:1879113
7. Gleason CA, Devaskar SU, Avery ME. Avery's diseases of the newborn /[edited by] Christine A. Gleason, Sherin U. Devaskar. Philadelphia, PA: Elsevier/Saunders, 2012.
8. Voora S, Srinivasan G, Lilien LD, Yeh TF, Pildes RS. Fever in full-term newborns in the first four days of life. Pediatrics 1982; 69:40-4. PMID:7033912
9. Weisman LE, Stoll BJ, Cruess DF, Hall RT, Merenstein GB, Hemming VG, Fischer GW. Earlyonset group B streptococcal sepsis: a current assessment. J Pediatr 1992; 121:428-33. PMID:1517922; http://dx.doi.org/10.1016/S0022-3476(05)81801-3
10. Hofer N, Müller W, Resch B. Neonates presenting with temperature symptoms: role in the diagnosis of early onset sepsis. Pediatr Int 2012; 54:486-90. PMID:22299645; http://dx.doi.org/10.1111/j.1442-200X.2012.03570.x
11. Bekhof J, Reitsma JB, Kok JH, Van Straaten IH. Clinical signs to identify late-onset sepsis in preterm infants. Eur J Pediatr 2013; 172:501-8. PMID:23271492; http://dx.doi.org/10.1007/s00431-012-1910-6
12. Remington JS. Infectious diseases of the fetus and newborn infant. Philadelphia, PA: Saunders/Elsevier, 2011.
13. Martin RJ, Fanaroff AA, Walsh MC. Fanaroff and Martin's neonatal-perinatal medicine: diseases of the fetus and infant. Philadelphia: Saunders/Elsevier, 2011.
14. Sharma R, Tepas JJ 3rd, Hudak ML, Wludyka PS, Mollitt DL, Garrison RD, Bradshaw JA, Sharma M. Portal venous gas and surgical outcome of neonatal necrotizing enterocolitis. J Pediatr Surg 2005; 40:371-6. PMID:15750931; http://dx.doi.org/10.1016/j.jpedsurg.2004.10.022
15. Sharma R, Tepas JJ 3rd, Hudak ML, Pieper P, Teng RJ, Raja S, Sharma M. Neonatal gut injury and infection rate: impact of surgical debridement on outcome. Pediatr Surg Int 2005; 21:977-82. PMID:16211416; http://dx.doi.org/10.1007/s00383-005-1539-x
16. Cole CR, Hansen NI, Higgins RD, Bell EF, Shankaran S, Laptook AR, Walsh MC, Hale EC, Newman NS, Das A, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development's Neonatal Research Network. Bloodstream infections in very low birth weight infants with intestinal failure. J Pediatr 2012; 160:54, e2. PMID:21840538; http://dx.doi.org/10.1016/j.jpeds.2011.06.034
17. Chaaban H, Shin M, Sirya E, Lim YP, Caplan M, Padbury JF. Inter-alpha inhibitor protein level in neonates predicts necrotizing enterocolitis. J Pediatr 2010; 157:757-61. PMID:20955849; http://dx.doi.org/10.1016/j.jpeds.2010.04.075
18. Uauy RD, Fanaroff AA, Korones SB, Phillips EA, Phillips JB, Wright LL; National Institute of Child Health and Human Development Neonatal Research Network. Necrotizing enterocolitis in very low birth weight infants: biodemographic and clinical correlates. J Pediatr 1991; 119:630-8. PMID:1919897; http://dx.doi.org/10.1016/S0022-3476(05)82418-7
19. Sharma R, Hudak ML. A clinical perspective of necrotizing enterocolitis: past, present, and future. Clin Perinatol 2013; 40:27-51. PMID:23415262; http://dx.doi.org/10.1016/j.clp.2012.12.012
20. Kaufman D, Fairchild KD. Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. [table of contents.]. Clin Microbiol Rev 2004; 17:638-80. PMID:15258097; http://dx.doi.org/10.1128/CMR.17.3.638-680.2004
21. Baker CJ, Barrett FF. Group B streptococcal infections in infants. The importance of the various serotypes. JAMA 1974; 230:1158-60. PMID:4608888; http://dx.doi.org/10.1001/jama.1974.03240080040025
22. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA, Donovan EF, Stark AR, Tyson JE, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002; 110:285-91. PMID:12165580; http://dx.doi.org/10.1542/peds.110.2.285
23. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA, Donovan EF, Stark AR, Tyson JE, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002; 347:240-7. PMID:12140299; http://dx.doi.org/10.1056/NEJMoa012657
24. Stoll BJ, Hansen NI, Sánchez PJ, Faix RG, Poindexter BB, Van Meurs KP, Bizzarro MJ, Goldberg RN, Frantz ID 3rd, Hale EC, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics 2011; 127:817-26. PMID:21518717; http://dx.doi.org/10.1542/peds.2010-2217
25. Weston EJ, Pondo T, Lewis MM, Martell-Cleary P, Morin C, Jewell B, Daily P, Apostol M, Petit S, Farley M, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J 2011; 30:937-41. PMID:21654548; http://dx.doi.org/10.1097/INF.0b013e318223bad2
26. Baltimore RS, Huie SM, Meek JI, Schuchat A, O'Brien KL. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics 2001; 108:1094-8. PMID:11694686; http://dx.doi.org/10.1542/peds.108.5.1094
27. Gladstone IM, Ehrenkranz RA, Edberg SC, Baltimore RS. A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience. Pediatr Infect Dis J 1990; 9:819-25. PMID:2263432; http://dx.doi.org/10.1097/00006454-199011000-00009
28. Karlowicz MG, Buescher ES, Surka AE. Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy. Pediatrics 2000; 106:1387-90. PMID:11099593; http://dx.doi.org/10.1542/peds.106.6.1387
29. Levent F, Baker CJ, Rench MA, Edwards MS. Early outcomes of group B streptococcal meningitis in the 21st century. Pediatr Infect Dis J 2010; 29:1009-12. PMID:20555292
30. Libster R, Edwards KM, Levent F, Edwards MS, Rench MA, Castagnini LA, Cooper T, Sparks RC, Baker CJ, Shah PE. Long-term outcomes of group B streptococcal meningitis. Pediatrics 2012; 130:e8-15. PMID:22689869; http://dx.doi.org/10.1542/peds.2011-3453
31. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Recomm Rep 1996; 45(RR-7):1-24. PMID:8637497
32. Desa DJ, Trevenen CL. Intrauterine infections with group B beta-haemolytic streptococci. Br J Obstet Gynaecol 1984; 91:237-9. PMID:6367810; http://dx.doi.org/10.1111/j.1471-0528.1984.tb04759.x
33. Katz V, Bowes WA Jr. Perinatal group B streptococcal infections across intact amniotic membranes. J Reprod Med 1988; 33:445-9. PMID:3290476
34. Regan JA, Klebanoff MA, Nugent RP; Vaginal Infections and Prematurity Study Group. The epidemiology of group B streptococcal colonization in pregnancy. Obstet Gynecol 1991; 77:604-10. PMID:2002986
35. Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59(RR-10):1-36. PMID:21088663
36. Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, Harrison LH, Reingold A, Stefonek K, Smith G, et al.; Active Bacterial Core Surveillance Team. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002; 347:233-9. PMID:12140298; http://dx.doi.org/10.1056/NEJMoa020205
37. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002; 51(RR-11):1-22. PMID:12211284
38. Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR CDC Surveill Summ 1992; 41:25-32. PMID:1470102
39. Levine EM, Ghai V, Barton JJ, Strom CM. Intrapartum antibiotic prophylaxis increases the incidence of gram-negative neonatal sepsis. Infect Dis Obstet Gynecol 1999; 7:210-3. PMID:10449272
40. Polin RA; Committee on Fetus and Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics 2012; 129:1006-15. PMID:22547779; http://dx.doi.org/10.1542/peds.2012-0541
41. Puopolo KM, Draper D, Wi S, Newman TB, Zupancic J, Lieberman E, Smith M, Escobar GJ. Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors. Pediatrics 2011; 128:e1155-63. PMID:22025590; http://dx.doi.org/10.1542/peds.2010-3464
42. Puopolo KM, Escobar GJ. Early-onset sepsis: a predictive model based on maternal risk factors. Curr Opin Pediatr 2013; 25:161-6. PMID:23407183; http://dx.doi.org/10.1097/MOP.0b013e32835e1f96
43. Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6:2-8. PMID:15636651; http://dx.doi.org/10.1097/01.PCC.0000149131.72248.E6
44. Hornik CP, Benjamin DK, Becker KC, Benjamin DK Jr., Li J, Clark RH, Cohen-Wolkowiez M, Smith PB. Use of the complete blood cell count in early-onset neonatal sepsis. Pediatr Infect Dis J 2012; 31:799-802. PMID:22531231; http://dx.doi.org/10.1097/INF.0b013e318256905c
45. Kellogg JA, Ferrentino FL, Goodstein MH, Liss J, Shapiro SL, Bankert DA. Frequency of low level bacteremia in infants from birth to two months of age. Pediatr Infect Dis J 1997; 16:381-5. PMID:9109140; http://dx.doi.org/10.1097/00006454199704000-00009
46. Brozanski BS, Jones JG, Krohn MJ, Jordan JA. Use of polymerase chain reaction as a diagnostic tool for neonatal sepsis can result in a decrease in use of antibiotics and total neonatal intensive care unit length of stay. J Perinatol 2006; 26:688-92. PMID:17024143; http://dx.doi.org/10.1038/sj.jp.7211597
47. Rozycki HJ, Stahl GE, Baumgart S. Impaired sensitivity of a single early leukocyte count in screening for neonatal sepsis. Pediatr Infect Dis J 1987; 6:440-2. PMID:3601489; http://dx.doi.org/10.1097/00006454-198705000-00004
48. Christensen RD, Rothstein G, Hill HR, Hall RT. Fatal early onset group B streptococcal sepsis with normal leukocyte counts. Pediatr Infect Dis 1985; 4:242-5. PMID:3889873; http://dx.doi.org/10.1097/00006454-198505000-00006
49. Murphy K, Weiner J. Use of leukocyte counts in evaluation of early-onset neonatal sepsis. Pediatr Infect Dis J 2012; 31:16-9. PMID:21860335; http://dx.doi.org/10.1097/INF.0b013e31822ffc17
50. Manroe BL, Weinberg AG, Rosenfeld CR, Browne R. The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr 1979; 95:89-98. PMID:480023; http://dx.doi.org/10.1016/S0022-3476(79)80096-7
51. Schmutz N, Henry E, Jopling J, Christensen RD. Expected ranges for blood neutrophil concentrations of neonates: the Manroe and Mouzinho charts revisited. J Perinatol 2008; 28:275-81. PMID:18200025; http://dx.doi.org/10.1038/sj.jp.7211916
52. Hofer N, Zacharias E, Müller W, Resch B. An update on the use of C-reactive protein in earlyonset neonatal sepsis: current insights and new tasks. Neonatology 2012; 102:25-36. PMID:22507868; http://dx.doi.org/10.1159/000336629
53. Pourcyrous M, Bada HS, Korones SB, Baselski V, Wong SP. Significance of serial C-reactive protein responses in neonatal infection and other disorders. Pediatrics 1993; 92:431-5. PMID:8361798
54. Kawamura M, Nishida H. The usefulness of serial C-reactive protein measurement in managing neonatal infection. Acta Paediatr 1995; 84:10-3. PMID:7734887; http://dx.doi.org/10.1111/j.1651-2227.1995.tb13475.x
55. Franz AR, Steinbach G, Kron M, Pohlandt F. Reduction of unnecessary antibiotic therapy in newborn infants using interleukin-8 and C-reactive protein as markers of bacterial infections. Pediatrics 1999; 104:447-53. PMID:10469768; http://dx.doi.org/10.1542/peds.104.3.447
56. Ng PC. Diagnostic markers of infection in neonates. Arch Dis Child Fetal Neonatal Ed 2004; 89:F229-35. PMID:15102726; http://dx.doi.org/10.1136/adc.2002.023838
57. Benitz WE. Adjunct laboratory tests in the diagnosis of early-onset neonatal sepsis. Clin Perinatol 2010; 37:421-38. PMID:20569816; http://dx.doi.org/10.1016/j.clp.2009.12.001
58. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohuon C. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994; 79:1605-8. PMID:7989463; http://dx.doi.org/10.1210/jc.79.6.1605
59. Chiesa C, Panero A, Rossi N, Stegagno M, De Giusti M, Osborn JF, Pacifico L. Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis 1998; 26:664-72. PMID:9524841; http://dx.doi.org/10.1086/514576
60. Whicher J, Bienvenu J, Monneret G. Procalcitonin as an acute phase marker. Ann Clin Biochem 2001; 38:483-93. PMID:11587126; http://dx.doi.org/10.1258/0004563011901299
61. Chiesa C, Pellegrini G, Panero A, Osborn JF, Signore F, Assumma M, Pacifico L. C-reactive protein, interleukin- 6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem 2003; 49:60-8. PMID:12507961; http://dx.doi.org/10.1373/49.1.60
62. Altunhan H, Annagür A, Örs R, Mehmetoǧlu I. Procalcitonin measurement at 24 hours of age may be helpful in the prompt diagnosis of early-onset neonatal sepsis. Int J Infect Dis 2011; 15:e854-8. PMID:22019570; http://dx.doi.org/10.1016/j.ijid.2011.09.007
63. Assumma M, Signore F, Pacifico L, Rossi N, Osborn JF, Chiesa C. Serum procalcitonin concentrations in term delivering mothers and their healthy offspring: a longitudinal study. Clin Chem 2000; 46:1583-7. PMID:11017935
64. Miller LC, Isa S, LoPreste G, Schaller JG, Dinarello CA. Neonatal interleukin-1 beta, interleukin-6, and tumor necrosis factor: cord blood levels and cellular production. J Pediatr 1990; 117:961-5. PMID:2246700; http://dx.doi.org/10.1016/S0022-3476(05)80145-3
65. Mehr S, Doyle LW. Cytokines as markers of bacterial sepsis in newborn infants: a review. Pediatr Infect Dis J 2000; 19:879-87. PMID:11001114; http://dx.doi.org/10.1097/00006454-200009000-00014
66. Gonzalez BE, Mercado CK, Johnson L, Brodsky NL, Bhandari V. Early markers of late-onset sepsis in premature neonates: clinical, hematological and cytokine profile. J Perinat Med 2003; 31:60-8. PMID:12661146; http://dx.doi.org/10.1515/JPM.2003.009
67. Mishra UK, Jacobs SE, Doyle LW, Garland SM. Newer approaches to the diagnosis of early onset neonatal sepsis. Arch Dis Child Fetal Neonatal Ed 2006; 91:F208-12. PMID:16632649; http://dx.doi.org/10.1136/adc.2004.064188
68. Cernada M, Badía N, Modesto V, Alonso R, Mejías A, Golombek S, Vento M. Cord blood interleukin-6 as a predictor of early-onset neonatal sepsis. Acta Paediatr 2012; 101:e203-7. PMID:22211677; http://dx.doi.org/10.1111/j.1651-2227.2011.02577.x
69. Smulian JC, Vintzileos AM, Lai YL, Santiago J, Shen-Schwarz S, Campbell WA. Maternal chorioamnionitis and umbilical vein interleukin-6 levels for identifying early neonatal sepsis. J Matern Fetal Med 1999; 8:88-94. PMID:10338061; http://dx.doi.org/10.1002/(SICI)1520-6661(199905/06)8:388::AIDMFM43.0.CO;2-#
70. Wang ZL, Yu JL. [Recent progress in the diagnosis of neonatal septicemia]. Zhongguo Dang Dai Er Ke Za Zhi 2013; 15:236-41. PMID:23498771
71. Ng PC, Cheng SH, Chui KM, Fok TF, Wong MY, Wong W, Wong RP, Cheung KL. Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 1997; 77:F221-7. PMID:9462194; http://dx.doi.org/10.1136/fn.77.3.F221
72. Døllner H, Vatten L, Austgulen R. Early diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6, soluble tumour necrosis factor receptors and soluble adhesion molecules. J Clin Epidemiol 2001; 54:1251-7. PMID:11750194; http://dx.doi.org/10.1016/S0895-4356(01)00400-0
73. Berner R, Niemeyer CM, Leititis JU, Funke A, Schwab C, Rau U, Richter K, Tawfeek MS, Clad A, Brandis M. Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8, and soluble intercellular adhesion molecule- 1 in neonatal early onset sepsis. Pediatr Res 1998; 44:469-77. PMID:9773833; http://dx.doi.org/10.1203/00006450199810000-00002
74. Silveira RC, Procianoy RS. Evaluation of interleukin- 6, tumour necrosis factor-alpha and interleukin- 1beta for early diagnosis of neonatal sepsis. Acta Paediatr 1999; 88:647-50. PMID:10419250; http://dx.doi.org/10.1080/08035259950169314
75. de Bont ES, Martens A, van Raan J, Samson G, Fetter WP, Okken A, de Leij LH, Kimpen JL. Diagnostic value of plasma levels of tumor necrosis factor alpha (TNF alpha) and interleukin-6 (IL-6) in newborns with sepsis. Acta Paediatr 1994; 83:696-9. PMID:7949797; http://dx.doi.org/10.1111/j.1651-2227.1994.tb13121.x
76. Baggiolini M, Walz A, Kunkel SL. Neutrophilactivating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989; 84:1045-9. PMID:2677047; http://dx.doi.org/10.1172/JCI114265
77. Boskabadi H, Maamouri G, Afshari JT, Ghayour-Mobarhan M, Shakeri MT. Serum interleukin 8 level as a diagnostic marker in late neonatal sepsis. Iran J Pediatr 2010; 20:41-7. PMID:23056680
78. Lehr HA, Krombach F, Münzing S, Bodlaj R, Glaubitt SI, Seiffge D, Hübner C, von Andrian UH, Messmer K. In vitro effects of oxidized low density lipoprotein on CD11b/CD18 and L-selectin presentation on neutrophils and monocytes with relevance for the in vivo situation. Am J Pathol 1995; 146:218-27. PMID:7531948
79. Simms HH, D'Amico R. Lipopolysaccharide induces intracytoplasmic migration of the polymorphonuclear leukocyte CD11b/CD18 receptor. Shock 1995; 3:196-203. PMID:7773799; http://dx.doi.org/10.1097/00024382-199503000-00007
80. Nupponen I, Andersson S, Järvenpää AL, Kautiainen H, Repo H. Neutrophil CD11b expression and circulating interleukin-8 as diagnostic markers for early-onset neonatal sepsis. Pediatrics 2001; 108:E12. PMID:11433091; http://dx.doi.org/10.1542/peds.108.1.e12
81. Weirich E, Rabin RL, Maldonado Y, Benitz W, Modler S, Herzenberg LA, Herzenberg LA. Neutrophil CD11b expression as a diagnostic marker for early-onset neonatal infection. J Pediatr 1998; 132:445-51. PMID:9544899; http://dx.doi.org/10.1016/S0022-3476(98)70018-6
82. Ng PC, Li K, Wong RP, Chui KM, Wong E, Fok TF. Neutrophil CD64 expression: a sensitive diagnostic marker for late-onset nosocomial infection in very low birthweight infants. Pediatr Res 2002; 51:296-303. PMID:11861933; http://dx.doi.org/10.1203/00006450-200203000-00006
83. Weinschenk NP, Farina A, Bianchi DW. Premature infants respond to early-onset and late-onset sepsis with leukocyte activation. J Pediatr 2000; 137:345-50. PMID:10969258; http://dx.doi.org/10.1067/mpd.2000.107846
84. de Haas M, Vossebeld PJ, von dem Borne AE, Roos D. Fc gamma receptors of phagocytes. J Lab Clin Med 1995; 126:330-41. PMID:7561440
85. Fjaertoft G, Håkansson L, Ewald U, Foucard T, Venge P. Neutrophils from term and preterm newborn infants express the high affinity Fcgammareceptor I (CD64) during bacterial infections. Pediatr Res 1999; 45:871-6. PMID:10367781; http://dx.doi.org/10.1203/00006450-199906000-00016
86. Sánchez-Mejorada G, Rosales C. Signal transduction by immunoglobulin Fc receptors. J Leukoc Biol 1998; 63:521-33. PMID:9581795
87. Herra CM, Keane CT, Whelan A. Increased expression of Fc gamma receptors on neutrophils and monocytes may reflect ongoing bacterial infection. J Med Microbiol 1996; 44:135-40. PMID:8642575; http://dx.doi.org/10.1099/00222615-44-2-135
88. Leino L, Sorvajärvi K, Katajisto J, Laine M, Lilius EM, Pelliniemi TT, Rajamäki A, Silvoniemi P, Nikoskelainen J. Febrile infection changes the expression of IgG Fc receptors and complement receptors in human neutrophils in vivo. Clin Exp Immunol 1997; 107:37-43. PMID:9010254; http://dx.doi.org/10.1046/j.1365-2249.1997.d01-899.x
89. Streimish I, Bizzarro M, Northrup V, Wang C, Renna S, Koval N, Li FY, Ehrenkranz R, Rinder HM, Bhandari V. Neutrophil CD64 as a diagnostic marker in neonatal sepsis. Pediatr Infect Dis J 2012; 31:777-81. PMID:22481422; http://dx.doi.org/10.1097/INF.0b013e318256fb07
90. Esparcia O, Montemayor M, Ginovart G, Pomar V, Soriano G, Pericas R, Gurgui M, Sulleiro E, Prats G, Navarro F, et al. Diagnostic accuracy of a 16S ribosomal DNA gene-based molecular technique (RT-PCR, microarray, and sequencing) for bacterial meningitis, early-onset neonatal sepsis, and spontaneous bacterial peritonitis. Diagn Microbiol Infect Dis 2011; 69:153-60. PMID:21251558; http://dx.doi.org/10.1016/j.diagmicrobio.2010.10.022
91. Ng PC, Li K, Wong RP, Chui K, Wong E, Li G, Fok TF. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed 2003; 88:F209-13. PMID:12719394; http://dx.doi.org/10.1136/fn.88.3.F209
92. Ng PC, Ang IL, Chiu RW, Li K, Lam HS, Wong RP, Chui KM, Cheung HM, Ng EW, Fok TF, et al. Host-response biomarkers for diagnosis of lateonset septicemia and necrotizing enterocolitis in preterm infants. J Clin Invest 2010; 120:2989-3000. PMID:20592468; http://dx.doi.org/10.1172/JCI40196
93. Kasper DC, Altiok I, Mechtler TP, Böhm J, Straub J, Langgartner M, Pollak A, Herkner KR, Berger A. Molecular detection of late-onset neonatal sepsis in premature infants using small blood volumes: proof-of-concept. Neonatology 2013; 103:268-73. PMID:23485823; http://dx.doi.org/10.1159/000346365
94. Bhandari V, Wang C, Rinder C, Rinder H. Hematologic profile of sepsis in neonates: neutrophil CD64 as a diagnostic marker. Pediatrics 2008; 121:129-34. PMID:18166566; http://dx.doi.org/10.1542/peds.2007-1308
95. Fries E, Blom AM. Bikunin--not just a plasma proteinase inhibitor. Int J Biochem Cell Biol 2000; 32:125-37. PMID:10687949; http://dx.doi.org/10.1016/S1357-2725(99)00125-9
96. Wachter E, Hochstrasser K. Kunitz-type proteinase inhibitors derived by limited proteolysis of the inter-alpha-trypsin inhibitor, IV. The amino acid sequence of the human urinary trypsin inhibitor isolated by affinity chromatography. Hoppe Seylers Z Physiol Chem 1981; 362:1351-5. PMID:6171496; http://dx.doi.org/10.1515/bchm2.1981.362.2.1351
97. Baek YW, Brokat S, Padbury JF, Pinar H, Hixson DC, Lim YP. Inter-alpha inhibitor proteins in infants and decreased levels in neonatal sepsis. J Pediatr 2003; 143:11-5. PMID:12915817; http://dx.doi.org/10.1016/S0022-3476(03)00190-2
98. Chaaban H, Singh K, Huang J, Siryaporn E, Lim YP, Padbury JF. The role of inter-alpha inhibitor proteins in the diagnosis of neonatal sepsis. J Pediatr 2009; 154:620, e1. PMID:19324226; http://dx.doi.org/10.1016/j.jpeds.2008.10.008
99. Yang S, Lim YP, Zhou M, Salvemini P, Schwinn H, Josic D, Koo DJ, Chaudry IH, Wang P. Administration of human inter-alpha-inhibitors maintains hemodynamic stability and improves survival during sepsis. Crit Care Med 2002; 30:617-22. PMID:11990925; http://dx.doi.org/10.1097/00003246-200203000-00021
100. Lim YP, Bendelja K, Opal SM, Siryaporn E, Hixson DC, Palardy JE. Correlation between mortality and the levels of inter-alpha inhibitors in the plasma of patients with severe sepsis. J Infect Dis 2003; 188:919-26. PMID:12964125; http://dx.doi.org/10.1086/377642
101. Singh K, Zhang LX, Bendelja K, Heath R, Murphy S, Sharma S, Padbury JF, Lim YP. Inter-alpha inhibitor protein administration improves survival from neonatal sepsis in mice. Pediatr Res 2010; 68:242-7. PMID:20520583; http://dx.doi.org/10.1203/PDR.0b013e3181e9fdf0